Valion Bio, Inc.
VBIO—
Valion Bio, Inc.VBIO$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-19.68
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$780,000
Net income
$-8.88M
Net margin
-1138.2%
Gross margin
0.3%
Dividends & financials
Valion Bio, Inc. (VBIO) reported revenue of $780,000 and net income of $-8.88M, or $-19.68 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.